护士在肠易激综合征管理中的作用：一项叙述性综述
The Role of the Nurse in the Management of Irritable Bowel Syndrome: A Narrative Review.
作者信息
Ruggiero Luigi, Andretta Vincenzo, Soldaini Carlo, Fricano Ivan, Mancusi Marco, Sellitti Annamaria, Vastarella Josephine, Santonicola Antonella
机构信息
Gastrointestinal Unit, Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Baronissi, SA, Italy.
AOU San Giovanni di Dio e Ruggi d'Aragona, Salerno, Italy.
出版信息
Transl Med UniSa. 2023 Dec 22;25(1):28-37. doi: 10.37825/2239-9747.1043. eCollection 2023.
Abstract
Irritable bowel syndrome (IBS) is characterized by chronic symptoms of abdominal pain in association with changes in bowel habits. Abdominal pain is the most debilitating symptom for IBS patients, and its management is one of the greatest challenges for gastroenterologists. In recent years more evidence has arisen about an increasingly central role of the nurse in the management of gastrointestinal diseases including IBS. The aim of this narrative review is to analyse the latest evidence on the pathophysiology, diagnosis, and treatment of IBS patients with a specific focus on the role of the nurse in its management.
摘要
肠易激综合征（IBS）的特征是伴有排便习惯改变的慢性腹痛症状。腹痛是IBS患者最使人衰弱的症状，对其进行管理是胃肠病学家面临的最大挑战之一。近年来，越来越多的证据表明护士在包括IBS在内的胃肠道疾病管理中发挥着越来越核心的作用。本叙述性综述的目的是分析IBS患者病理生理学、诊断和治疗的最新证据，特别关注护士在其管理中的作用。
相似文献
1
The Role of the Nurse in the Management of Irritable Bowel Syndrome: A Narrative Review.护士在肠易激综合征管理中的作用：一项叙述性综述
Transl Med UniSa. 2023 Dec 22;25(1):28-37. doi: 10.37825/2239-9747.1043. eCollection 2023.
2
Physical activity for treatment of irritable bowel syndrome.体力活动治疗肠易激综合征。
Cochrane Database Syst Rev. 2022 Jun 29;6(6):CD011497. doi: 10.1002/14651858.CD011497.pub2.
3
Food Intolerances, Food Allergies and IBS: Lights and Shadows.食物不耐受、食物过敏与肠易激综合征：利弊共存。
Nutrients. 2024 Jan 16;16(2):265. doi: 10.3390/nu16020265.
4
A Narrative Review of Irritable Bowel Syndrome with Diarrhea: A Primer for Primary Care Providers.腹泻型肠易激综合征的叙事性综述：基层医疗保健提供者指南。
Adv Ther. 2022 Sep;39(9):4003-4020. doi: 10.1007/s12325-022-02224-z. Epub 2022 Jul 22.
5
Chronic abdominal pain in irritable bowel syndrome - current and future therapies.肠易激综合征的慢性腹痛——当前和未来的治疗方法。
Expert Rev Clin Pharmacol. 2018 Jul;11(7):729-739. doi: 10.1080/17512433.2018.1494571. Epub 2018 Jul 9.
6
Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With Diarrhea.腹泻型肠易激综合征的药物治疗及其临床靶点
Front Pharmacol. 2021 Feb 18;11:629026. doi: 10.3389/fphar.2020.629026. eCollection 2020.
7
Endocrine regulation of gut function - a role for glucagon-like peptide-1 in the pathophysiology of irritable bowel syndrome.肠道功能的内分泌调节——胰高血糖素样肽-1在肠易激综合征病理生理学中的作用
Exp Physiol. 2019 Jan;104(1):3-10. doi: 10.1113/EP087443. Epub 2018 Dec 10.
8
Update on Eluxadoline for the Treatment of Irritable Bowel Syndrome with Diarrhea: Patient Selection and Perspectives.关于 Eluxadoline 治疗腹泻型肠易激综合征的最新进展：患者选择和观点。
Drug Des Devel Ther. 2020 Apr 9;14:1391-1400. doi: 10.2147/DDDT.S216056. eCollection 2020.
9
Managing pain in irritable bowel syndrome: current perspectives and best practice.肠易激综合征的疼痛管理：当前观点与最佳实践
Expert Rev Gastroenterol Hepatol. 2023 Jul-Dec;17(9):871-881. doi: 10.1080/17474124.2023.2242775. Epub 2023 Aug 8.
10
Are bowel symptoms and psychosocial features different in irritable bowel syndrome patients with abdominal discomfort compared to abdominal pain?肠症状和社会心理特征在伴有腹部不适的肠易激综合征患者中与腹痛患者有何不同？
World J Gastroenterol. 2022 Sep 7;28(33):4861-4874. doi: 10.3748/wjg.v28.i33.4861.
本文引用的文献
1
Randomised, placebo-controlled trial and meta-analysis show benefit of ondansetron for irritable bowel syndrome with diarrhoea: The TRITON trial.随机、安慰剂对照试验和荟萃分析显示昂丹司琼对腹泻型肠易激综合征有益：TRITON 试验。
Aliment Pharmacol Ther. 2023 Jun;57(11):1258-1271. doi: 10.1111/apt.17426. Epub 2023 Mar 3.
2
Nurse practitioner-delivered cognitive-behavioral treatment as a novel implementation route for irritable bowel syndrome: A proof of concept.护士从业者提供的认知行为治疗作为一种新颖的肠易激综合征实施途径：概念验证。
Neurogastroenterol Motil. 2023 Apr;35(4):e14526. doi: 10.1111/nmo.14526. Epub 2023 Jan 20.
3
Italian guidelines for the management of irritable bowel syndrome: Joint Consensus from the Italian Societies of: Gastroenterology and Endoscopy (SIGE), Neurogastroenterology and Motility (SINGEM), Hospital Gastroenterologists and Endoscopists (AIGO), Digestive Endoscopy (SIED), General Medicine (SIMG), Gastroenterology, Hepatology and Pediatric Nutrition (SIGENP) and Pediatrics (SIP).意大利肠易激综合征管理指南：来自意大利胃肠病学与内镜学会（SIGE）、神经胃肠病学与动力学会（SINGEM）、医院胃肠病学家与内镜医师学会（AIGO）、消化内镜学会（SIED）、普通医学学会（SIMG）、胃肠病学、肝病学与儿科营养学会（SIGENP）以及儿科学会（SIP）的联合共识
Dig Liver Dis. 2023 Feb;55(2):187-207. doi: 10.1016/j.dld.2022.11.015. Epub 2022 Dec 11.
4
Low FODMAP diet reduces gastrointestinal symptoms in irritable bowel syndrome and clinical response could be predicted by symptom severity: A randomized crossover trial.低 FODMAP 饮食可减轻肠易激综合征的胃肠道症状，且临床应答可根据症状严重程度预测：一项随机交叉试验。
Clin Nutr. 2022 Dec;41(12):2792-2800. doi: 10.1016/j.clnu.2022.11.001. Epub 2022 Nov 4.
5
How to Implement the 3-Phase FODMAP Diet Into Gastroenterological Practice.如何将三相FODMAP饮食应用于胃肠病学实践。
J Neurogastroenterol Motil. 2022 Jul 30;28(3):343-356. doi: 10.5056/jnm22035.
6
The effect of self-management online modules plus nurse-led support on pain and quality of life among young adults with irritable bowel syndrome: A randomized controlled trial.自我管理在线模块加护士主导支持对年轻成人肠易激综合征疼痛和生活质量的影响：一项随机对照试验。
Int J Nurs Stud. 2022 Aug;132:104278. doi: 10.1016/j.ijnurstu.2022.104278. Epub 2022 Apr 30.
7
Association between irritable bowel syndrome and micronutrients: A systematic review.肠易激综合征与微量营养素的相关性：系统综述。
J Gastroenterol Hepatol. 2022 Aug;37(8):1485-1497. doi: 10.1111/jgh.15891. Epub 2022 May 28.
8
Efficacy and Acceptability of Dietary Therapies in Non-Constipated Irritable Bowel Syndrome: A Randomized Trial of Traditional Dietary Advice, the Low FODMAP Diet, and the Gluten-Free Diet.非便秘型肠易激综合征的饮食疗法的疗效和可接受性：传统饮食建议、低 FODMAP 饮食和无麸质饮食的随机试验。
Clin Gastroenterol Hepatol. 2022 Dec;20(12):2876-2887.e15. doi: 10.1016/j.cgh.2022.02.045. Epub 2022 Feb 28.
9
A systematic review and meta-analysis on the prevalence of non-malignant, organic gastrointestinal disorders misdiagnosed as irritable bowel syndrome.一项关于被误诊为肠易激综合征的非恶性、器质性胃肠道疾病患病率的系统评价和荟萃分析。
Sci Rep. 2022 Feb 4;12(1):1949. doi: 10.1038/s41598-022-05933-1.
10
Health care utilization of individuals with Rome IV irritable bowel syndrome in the general population.普通人群中罗马 IV 肠易激综合征患者的医疗保健利用情况。
United European Gastroenterol J. 2021 Dec;9(10):1178-1188. doi: 10.1002/ueg2.12153. Epub 2021 Oct 1.
Zotero 插件